HIV/AIDS Archives - Page 2 of 43

Prophylactic Effects of Dolutegravir in Infants With HIV Transmission Risk

By

March 9, 2021

Investigators used data from mothers and infants enrolled in the DolPHIN-1 trial to develop a population pharmacokinetic model of dolutegravir.

Infectious Diseases Information Center

High Prevalence of Antibiotic Resistance in Men Who Have Sex With Men

By

Bradley van Paridon

February 18, 2021

The goal of this study was to assess the impact of doxycycline PEP on M genitalium, an emerging pathogen among men who have sex with men that has rising rates of antibiotic resistance.

Infectious Diseases Information Center

COVID-19 Outcomes Worse for Patients with HIV

February 10, 2021

Persons living with HIV who are diagnosed with COVID-19 are more likely to require hospitalization and to die.

Although sensitivity is an important consideration when deciding among HIV tests, there are other factors to consider, such as test invasiveness, available resources, need for additional studies, and patient adherence.6 Serum- and plasma-based HIV testing is the most invasive and requires the most resources, such as access to a skilled clinician or phlebotomist and access to special equipment (eg, needles, biohazard containers, laboratory). Whole blood testing can be performed by venipuncture or finger-stick. When blood-based tests yield a sufficient specimen sample using venipuncture, additional studies can be undertaken, such as HIV subtyping and assessment for coinfections, including hepatitis or syphilis. In contrast, oral fluid tests do not require special equipment and can be performed in any setting, including at home, providing results in minutes. These tests also eliminate safety and biohazard concerns, such as needlestick injuries and sharps disposal.

HIV/AIDS Information Center

Updated IDSA Guidance on Primary Care for HIV Released

By

Brandon May

February 9, 2021

The HIV Medicine Association of the Infectious Diseases Society of America published an updated primary care guidance for persons with HIV.

Practice Management Information Center

Top January 2021 FDA Approvals

By

Michelle Lampariello

February 4, 2021

January 2021 FDA approvals of import to physician assistants and nurse practitioners include treatments for HIV, heart failure, dry eye disease, and light chain amyloidosis.

HIV/AIDS Information Center

Cabenuva Approved as First Long-Acting Injectable for HIV Treatment

By

Brian Park, PharmD

January 25, 2021

The approval of Cabenuva was based on data from two phase 3 trials which included 1182 HIV-infected adults who were virologically suppressed (HIV-1 RNA less than 50 copies/mL) prior to initiation.

HPV Information Center

Incidence and Clearance of High-Risk HPV in Gay and Bisexual Men

By

Bradley van Paridon

January 20, 2021

Investigators examined incidence, clearance, and risk factors for 13 high-risk human papilloma virus types in gay and bisexual men with HIV.

HIV/AIDS Information Center

Counterfeit HIV Drug Identified in 3 US Pharmacies

By

Diana Ernst, RPh

January 4, 2021

The counterfeit products were procured from unauthorized distributors.

HIV/AIDS Information Center

IAS Panel Releases Updated 2020 Guidelines on ART and HIV Prevention

By

Brandon May

December 7, 2020

The International Antiviral Society published updated 2020 recommendations on use of antiretroviral therapy, laboratory monitoring and screening, prevention, and management of older patients living with HIV.